Beyond PD-1 Immunotherapy in Malignant Melanoma

Dominika Kwiatkowska(University of Rzeszów), Adam Reich(Rzeszów University of Technology), Piotr Kluska(Wrocław University of Science and Technology)

Dermatology and Therapy

March 29, 2019

10.1007/s13555-019-0292-3

Cited by 27

Related Papers

Definition of treatment goals for moderate to severe psoriasis: a European consensus

|Archives of Dermatological Research|2010|892

Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus

|Acta Dermato Venereologica|2012|579

Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus

|Acta Dermato Venereologica|2012|502

Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

|BMC Cancer|2018|382

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

|The Lancet|2023|318